Connect® MM - The Multiple Myeloma Disease Registry

The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.


This research study is led by Dr. Armen Asik.

Contact: Dawn DeMarinis, 413-794-4362

Participation details:

Cancer - Multiple Myeloma, Cancer
Baystate Medical Center, 759 Chestnut St, Springfield, MA

Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Sampling Method: Non-Probability Sample

Inclusion Criteria:

  • Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect®MM registry
  • Age ≥18 years
  • Willing and able to provide signed informed consent
  • Agrees to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel